Kestra Medical Technologies (KMTS) Competitors $22.96 -1.10 (-4.57%) As of 05/1/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock KMTS vs. BLCO, INSP, NARI, SLNO, IRTC, TMDX, PRCT, NVST, LMAT, and NVCRShould you be buying Kestra Medical Technologies stock or one of its competitors? The main competitors of Kestra Medical Technologies include Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), Inari Medical (NARI), Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), TransMedics Group (TMDX), PROCEPT BioRobotics (PRCT), Envista (NVST), LeMaitre Vascular (LMAT), and NovoCure (NVCR). These companies are all part of the "medical equipment" industry. Kestra Medical Technologies vs. Bausch + Lomb Inspire Medical Systems Inari Medical Soleno Therapeutics iRhythm Technologies TransMedics Group PROCEPT BioRobotics Envista LeMaitre Vascular NovoCure Bausch + Lomb (NYSE:BLCO) and Kestra Medical Technologies (NASDAQ:KMTS) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, community ranking, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations. Does the MarketBeat Community believe in BLCO or KMTS? Bausch + Lomb received 36 more outperform votes than Kestra Medical Technologies when rated by MarketBeat users. However, 71.43% of users gave Kestra Medical Technologies an outperform vote while only 41.41% of users gave Bausch + Lomb an outperform vote. CompanyUnderperformOutperformBausch + LombOutperform Votes4141.41% Underperform Votes5858.59% Kestra Medical TechnologiesOutperform Votes571.43% Underperform Votes228.57% Do analysts prefer BLCO or KMTS? Bausch + Lomb presently has a consensus price target of $16.86, indicating a potential upside of 45.46%. Kestra Medical Technologies has a consensus price target of $27.50, indicating a potential upside of 19.77%. Given Bausch + Lomb's higher possible upside, equities analysts clearly believe Bausch + Lomb is more favorable than Kestra Medical Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch + Lomb 1 Sell rating(s) 7 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.25Kestra Medical Technologies 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 Which has better earnings and valuation, BLCO or KMTS? Kestra Medical Technologies has lower revenue, but higher earnings than Bausch + Lomb. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBausch + Lomb$4.79B0.86-$317M-$0.91-12.74Kestra Medical Technologies$52.64M22.40N/AN/AN/A Is BLCO or KMTS more profitable? Kestra Medical Technologies has a net margin of 0.00% compared to Bausch + Lomb's net margin of -6.62%. Bausch + Lomb's return on equity of 3.35% beat Kestra Medical Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Bausch + Lomb-6.62% 3.35% 1.66% Kestra Medical Technologies N/A N/A N/A Does the media prefer BLCO or KMTS? In the previous week, Bausch + Lomb had 13 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 18 mentions for Bausch + Lomb and 5 mentions for Kestra Medical Technologies. Kestra Medical Technologies' average media sentiment score of 0.64 beat Bausch + Lomb's score of 0.04 indicating that Kestra Medical Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bausch + Lomb 3 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Kestra Medical Technologies 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals have more ownership in BLCO or KMTS? 11.1% of Bausch + Lomb shares are owned by institutional investors. 0.8% of Bausch + Lomb shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. SummaryBausch + Lomb beats Kestra Medical Technologies on 8 of the 14 factors compared between the two stocks. Get Kestra Medical Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for KMTS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KMTS vs. The Competition Export to ExcelMetricKestra Medical TechnologiesSurgical, Medical, And Dental Instruments And Supplies IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$1.18B$366.36M$2.02B$7.93BDividend YieldN/AN/A2.70%4.23%P/E RatioN/AN/A22.5118.55Price / Sales22.407.7859.38103.29Price / CashN/AN/A51.7234.62Price / BookN/AN/A2.004.25Net IncomeN/AN/A-$333.48M$248.18M7 Day Performance-5.28%3.79%0.53%0.91%1 Month Performance-10.66%4.45%-0.92%2.58%1 Year PerformanceN/A177.37%7.77%4.02% Kestra Medical Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KMTSKestra Medical TechnologiesN/A$22.96-4.6%$27.50+19.8%N/A$1.18B$52.64M0.00300Positive NewsBLCOBausch + Lomb3.7037 of 5 stars$13.90+9.1%$18.82+35.4%-15.6%$4.91B$4.79B-15.2712,500Earnings ReportAnalyst ForecastNews CoverageINSPInspire Medical Systems4.8553 of 5 stars$158.26+6.7%$218.90+38.3%-35.2%$4.71B$802.80M91.48760Upcoming EarningsNARIInari MedicalN/A$79.97flat$68.00-15.0%N/A$4.68B$493.63M-59.24800SLNOSoleno Therapeutics4.647 of 5 stars$74.23+2.7%$104.67+41.0%+57.8%$3.40BN/A-22.3630Upcoming EarningsNews CoveragePositive NewsIRTCiRhythm Technologies0.96 of 5 stars$104.78+2.1%$119.73+14.3%-2.8%$3.34B$591.84M-28.791,790News CoverageTMDXTransMedics Group3.0491 of 5 stars$94.18+2.1%$122.70+30.3%-23.1%$3.19B$441.54M100.19210Upcoming EarningsAnalyst ForecastPositive NewsPRCTPROCEPT BioRobotics2.6967 of 5 stars$52.56-5.6%$91.43+74.0%-12.8%$2.88B$224.50M-26.95430Analyst RevisionHigh Trading VolumeNVSTEnvista3.8807 of 5 stars$15.99+1.7%$19.96+24.9%-17.1%$2.71B$2.51B-2.4612,700Earnings ReportAnalyst ForecastNews CoveragePositive NewsLMATLeMaitre Vascular1.9131 of 5 stars$91.76+2.5%$95.25+3.8%+35.1%$2.07B$219.86M50.14490Earnings ReportNews CoverageNVCRNovoCure3.8506 of 5 stars$18.55+4.4%$32.83+77.0%+40.9%$2.07B$605.22M-13.251,320 Related Companies and Tools Related Companies BLCO Alternatives INSP Alternatives NARI Alternatives SLNO Alternatives IRTC Alternatives TMDX Alternatives PRCT Alternatives NVST Alternatives LMAT Alternatives NVCR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KMTS) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kestra Medical Technologies, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kestra Medical Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KMTS Stock Free KMTS Stock Alerts